[1] Guven A, Alrijjal RA, Binessa H, et al.Mutational analysis of PHEX, FGF23 and CLCN5 in Patients with hypophosphataemic rickets[J]. Clin Endocrinol (Oxf),2017,87:103-112. [2] 张偲, 罗小平.低磷抗维生素D性佝偻病诊治进展[J]. 中国实用儿科杂志,2017,32(9):669-673. [3] 蔡汝刚.低血磷抗维生素D佝偻病诊断与治疗:附5例报告[J]. 临床儿科杂志,2005,23(11):805-806. [4] 杨慧明, 万朝敏, Tracey R,等.重组人类生长激素治疗儿童X-连锁低血磷性佝偻病[J]. 临床儿科杂志,2004,22(8):556-558. [5] Kinoshita Y, Fukumoto S.X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases-prospect for new treatment [J]. Endocr Rev,2018,39(3):274-291. [6] Tokarz D, Martins JS, Petit ET, et al.Hormonal regulation of osteocyte perilacunar and canalicular remodeling in the Hyp mouse model of XLH[J]. J Bone Miner Res,2018,33:499-509. [7] Fuente R, Gil-Pea H, Claramunt-Taberner D, et al.X-linked hypophosphatemia and growth[J]. Rev Endocr Metab Disord,2017,18(1):107-115.
PDF(2242 KB)
